COVID-19 Diagnostic Testing Market Insights, Global Outlook and Forecast 2022-2028
COVID-19 Diagnostic Testing Market Insights, Global Outlook and Forecast 2022-2028
The report classifies the business vertical into various segments based on components, voltage, end-user scope, and regional division. A thorough analysis of each segment with respect to their market share, growth rate, and revenue contribution forms a major part of the study.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
COVID-19 testing involves analysing samples that indicate the present or past presence of SARS-CoV-2. The two main branches detect either the presence of the virus or antibodies produced in response to infection.
The latest research study released by Market IntelliX evaluates market size and forecasts of COVID-19 Diagnostic Testing in Global, including the following market information:
Global COVID-19 Diagnostic Testing Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global COVID-19 Diagnostic Testing market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Nucleic Acid Testing Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of COVID-19 Diagnostic Testing include Cellex, Abbott, Roche, BioMedomics, BD, Henry Schein, Safecare Bio-Tech, Mayo Clinic Laboratories and Chembio Diagnostics, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MI has surveyed the COVID-19 Diagnostic Testing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Market Segmentations:
Global COVID-19 Diagnostic Testing Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global COVID-19 Diagnostic Testing Market Segment Percentages, by Type, 2021 (%)
Nucleic Acid Testing
Antibody Testing
Global COVID-19 Diagnostic Testing Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global COVID-19 Diagnostic Testing Market Segment Percentages, by Application, 2021 (%)
Hospitals
Scientific Research
Global COVID-19 Diagnostic Testing Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global COVID-19 Diagnostic Testing Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies COVID-19 Diagnostic Testing revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies COVID-19 Diagnostic Testing revenues share in global market, 2021 (%)
The report presents profiles of competitors in the market, Some of the prominent key players covered:
Cellex
Abbott
Roche
BioMedomics
BD
Henry Schein
Safecare Bio-Tech
Mayo Clinic Laboratories
Chembio Diagnostics
Mount Sinai Laboratory
Ortho Clinical Diagnostics
Zhejiang Orient Gene Biotech
Innovita Biological Technology
Guangzhou Wondfo Biotech
Guangdong Hecin-Scientific
Dynamiker Biotechnology (Tianjin)
ADVAITE
Key Takeaways from this Report
Evaluate market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level – for product types, end use applications and by different industry verticals.
Understand the different dynamics influencing the market – key driving factors, challenges and hidden opportunities.
Get in-depth insights on your competitor performance – market shares, strategies, financial benchmarking, product benchmarking, SWOT and more.
Analyze the sales and distribution channels across key geographies to improve top-line revenues.
Understand the industry supply chain with a deep-dive on the value augmentation at each step, in order to optimize value and bring efficiencies in your processes.
Get a quick outlook on the market entropy – M&A’s, deals, partnerships, product launches of all key players for the past 4 years.
Evaluate the supply-demand gaps, import-export statistics and regulatory landscape for more than top 20 countries globally for the market.
1 Introduction to Research & Analysis Reports
1.1 COVID-19 Diagnostic Testing Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global COVID-19 Diagnostic Testing Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global COVID-19 Diagnostic Testing Overall Market Size
2.1 Global COVID-19 Diagnostic Testing Market Size: 2021 VS 2028
2.2 Global COVID-19 Diagnostic Testing Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top COVID-19 Diagnostic Testing Players in Global Market
3.2 Top Global COVID-19 Diagnostic Testing Companies Ranked by Revenue
3.3 Global COVID-19 Diagnostic Testing Revenue by Companies
3.4 Top 3 and Top 5 COVID-19 Diagnostic Testing Companies in Global Market, by Revenue in 2021
3.5 Global Companies COVID-19 Diagnostic Testing Product Type
3.6 Tier 1, Tier 2 and Tier 3 COVID-19 Diagnostic Testing Players in Global Market
3.6.1 List of Global Tier 1 COVID-19 Diagnostic Testing Companies
3.6.2 List of Global Tier 2 and Tier 3 COVID-19 Diagnostic Testing Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global COVID-19 Diagnostic Testing Market Size Markets, 2021 & 2028
4.1.2 Nucleic Acid Testing
4.1.3 Antibody Testing
4.2 By Type - Global COVID-19 Diagnostic Testing Revenue & Forecasts
4.2.1 By Type - Global COVID-19 Diagnostic Testing Revenue, 2017-2022
4.2.2 By Type - Global COVID-19 Diagnostic Testing Revenue, 2023-2028
4.2.3 By Type - Global COVID-19 Diagnostic Testing Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global COVID-19 Diagnostic Testing Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Scientific Research
5.2 By Application - Global COVID-19 Diagnostic Testing Revenue & Forecasts
5.2.1 By Application - Global COVID-19 Diagnostic Testing Revenue, 2017-2022
5.2.2 By Application - Global COVID-19 Diagnostic Testing Revenue, 2023-2028
5.2.3 By Application - Global COVID-19 Diagnostic Testing Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global COVID-19 Diagnostic Testing Market Size, 2021 & 2028
6.2 By Region - Global COVID-19 Diagnostic Testing Revenue & Forecasts
6.2.1 By Region - Global COVID-19 Diagnostic Testing Revenue, 2017-2022
6.2.2 By Region - Global COVID-19 Diagnostic Testing Revenue, 2023-2028
6.2.3 By Region - Global COVID-19 Diagnostic Testing Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America COVID-19 Diagnostic Testing Revenue, 2017-2028
6.3.2 US COVID-19 Diagnostic Testing Market Size, 2017-2028
6.3.3 Canada COVID-19 Diagnostic Testing Market Size, 2017-2028
6.3.4 Mexico COVID-19 Diagnostic Testing Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe COVID-19 Diagnostic Testing Revenue, 2017-2028
6.4.2 Germany COVID-19 Diagnostic Testing Market Size, 2017-2028
6.4.3 France COVID-19 Diagnostic Testing Market Size, 2017-2028
6.4.4 U.K. COVID-19 Diagnostic Testing Market Size, 2017-2028
6.4.5 Italy COVID-19 Diagnostic Testing Market Size, 2017-2028
6.4.6 Russia COVID-19 Diagnostic Testing Market Size, 2017-2028
6.4.7 Nordic Countries COVID-19 Diagnostic Testing Market Size, 2017-2028
6.4.8 Benelux COVID-19 Diagnostic Testing Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia COVID-19 Diagnostic Testing Revenue, 2017-2028
6.5.2 China COVID-19 Diagnostic Testing Market Size, 2017-2028
6.5.3 Japan COVID-19 Diagnostic Testing Market Size, 2017-2028
6.5.4 South Korea COVID-19 Diagnostic Testing Market Size, 2017-2028
6.5.5 Southeast Asia COVID-19 Diagnostic Testing Market Size, 2017-2028
6.5.6 India COVID-19 Diagnostic Testing Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America COVID-19 Diagnostic Testing Revenue, 2017-2028
6.6.2 Brazil COVID-19 Diagnostic Testing Market Size, 2017-2028
6.6.3 Argentina COVID-19 Diagnostic Testing Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa COVID-19 Diagnostic Testing Revenue, 2017-2028
6.7.2 Turkey COVID-19 Diagnostic Testing Market Size, 2017-2028
6.7.3 Israel COVID-19 Diagnostic Testing Market Size, 2017-2028
6.7.4 Saudi Arabia COVID-19 Diagnostic Testing Market Size, 2017-2028
6.7.5 UAE COVID-19 Diagnostic Testing Market Size, 2017-2028
7 Players Profiles
7.1 Cellex
7.1.1 Cellex Corporate Summary
7.1.2 Cellex Business Overview
7.1.3 Cellex COVID-19 Diagnostic Testing Major Product Offerings
7.1.4 Cellex COVID-19 Diagnostic Testing Revenue in Global Market (2017-2022)
7.1.5 Cellex Key News
7.2 Abbott
7.2.1 Abbott Corporate Summary
7.2.2 Abbott Business Overview
7.2.3 Abbott COVID-19 Diagnostic Testing Major Product Offerings
7.2.4 Abbott COVID-19 Diagnostic Testing Revenue in Global Market (2017-2022)
7.2.5 Abbott Key News
7.3 Roche
7.3.1 Roche Corporate Summary
7.3.2 Roche Business Overview
7.3.3 Roche COVID-19 Diagnostic Testing Major Product Offerings
7.3.4 Roche COVID-19 Diagnostic Testing Revenue in Global Market (2017-2022)
7.3.5 Roche Key News
7.4 BioMedomics
7.4.1 BioMedomics Corporate Summary
7.4.2 BioMedomics Business Overview
7.4.3 BioMedomics COVID-19 Diagnostic Testing Major Product Offerings
7.4.4 BioMedomics COVID-19 Diagnostic Testing Revenue in Global Market (2017-2022)
7.4.5 BioMedomics Key News
7.5 BD
7.5.1 BD Corporate Summary
7.5.2 BD Business Overview
7.5.3 BD COVID-19 Diagnostic Testing Major Product Offerings
7.5.4 BD COVID-19 Diagnostic Testing Revenue in Global Market (2017-2022)
7.5.5 BD Key News
7.6 Henry Schein
7.6.1 Henry Schein Corporate Summary
7.6.2 Henry Schein Business Overview
7.6.3 Henry Schein COVID-19 Diagnostic Testing Major Product Offerings
7.6.4 Henry Schein COVID-19 Diagnostic Testing Revenue in Global Market (2017-2022)
7.6.5 Henry Schein Key News
7.7 Safecare Bio-Tech
7.7.1 Safecare Bio-Tech Corporate Summary
7.7.2 Safecare Bio-Tech Business Overview
7.7.3 Safecare Bio-Tech COVID-19 Diagnostic Testing Major Product Offerings
7.7.4 Safecare Bio-Tech COVID-19 Diagnostic Testing Revenue in Global Market (2017-2022)
7.7.5 Safecare Bio-Tech Key News
7.8 Mayo Clinic Laboratories
7.8.1 Mayo Clinic Laboratories Corporate Summary
7.8.2 Mayo Clinic Laboratories Business Overview
7.8.3 Mayo Clinic Laboratories COVID-19 Diagnostic Testing Major Product Offerings
7.8.4 Mayo Clinic Laboratories COVID-19 Diagnostic Testing Revenue in Global Market (2017-2022)
7.8.5 Mayo Clinic Laboratories Key News
7.9 Chembio Diagnostics
7.9.1 Chembio Diagnostics Corporate Summary
7.9.2 Chembio Diagnostics Business Overview
7.9.3 Chembio Diagnostics COVID-19 Diagnostic Testing Major Product Offerings
7.9.4 Chembio Diagnostics COVID-19 Diagnostic Testing Revenue in Global Market (2017-2022)
7.9.5 Chembio Diagnostics Key News
7.10 Mount Sinai Laboratory
7.10.1 Mount Sinai Laboratory Corporate Summary
7.10.2 Mount Sinai Laboratory Business Overview
7.10.3 Mount Sinai Laboratory COVID-19 Diagnostic Testing Major Product Offerings
7.10.4 Mount Sinai Laboratory COVID-19 Diagnostic Testing Revenue in Global Market (2017-2022)
7.10.5 Mount Sinai Laboratory Key News
7.11 Ortho Clinical Diagnostics
7.11.1 Ortho Clinical Diagnostics Corporate Summary
7.11.2 Ortho Clinical Diagnostics Business Overview
7.11.3 Ortho Clinical Diagnostics COVID-19 Diagnostic Testing Major Product Offerings
7.11.4 Ortho Clinical Diagnostics COVID-19 Diagnostic Testing Revenue in Global Market (2017-2022)
7.11.5 Ortho Clinical Diagnostics Key News
7.12 Zhejiang Orient Gene Biotech
7.12.1 Zhejiang Orient Gene Biotech Corporate Summary
7.12.2 Zhejiang Orient Gene Biotech Business Overview
7.12.3 Zhejiang Orient Gene Biotech COVID-19 Diagnostic Testing Major Product Offerings
7.12.4 Zhejiang Orient Gene Biotech COVID-19 Diagnostic Testing Revenue in Global Market (2017-2022)
7.12.5 Zhejiang Orient Gene Biotech Key News
7.13 Innovita Biological Technology
7.13.1 Innovita Biological Technology Corporate Summary
7.13.2 Innovita Biological Technology Business Overview
7.13.3 Innovita Biological Technology COVID-19 Diagnostic Testing Major Product Offerings
7.13.4 Innovita Biological Technology COVID-19 Diagnostic Testing Revenue in Global Market (2017-2022)
7.13.5 Innovita Biological Technology Key News
7.14 Guangzhou Wondfo Biotech
7.14.1 Guangzhou Wondfo Biotech Corporate Summary
7.14.2 Guangzhou Wondfo Biotech Business Overview
7.14.3 Guangzhou Wondfo Biotech COVID-19 Diagnostic Testing Major Product Offerings
7.14.4 Guangzhou Wondfo Biotech COVID-19 Diagnostic Testing Revenue in Global Market (2017-2022)
7.14.5 Guangzhou Wondfo Biotech Key News
7.15 Guangdong Hecin-Scientific
7.15.1 Guangdong Hecin-Scientific Corporate Summary
7.15.2 Guangdong Hecin-Scientific Business Overview
7.15.3 Guangdong Hecin-Scientific COVID-19 Diagnostic Testing Major Product Offerings
7.15.4 Guangdong Hecin-Scientific COVID-19 Diagnostic Testing Revenue in Global Market (2017-2022)
7.15.5 Guangdong Hecin-Scientific Key News
7.16 Dynamiker Biotechnology (Tianjin)
7.16.1 Dynamiker Biotechnology (Tianjin) Corporate Summary
7.16.2 Dynamiker Biotechnology (Tianjin) Business Overview
7.16.3 Dynamiker Biotechnology (Tianjin) COVID-19 Diagnostic Testing Major Product Offerings
7.16.4 Dynamiker Biotechnology (Tianjin) COVID-19 Diagnostic Testing Revenue in Global Market (2017-2022)
7.16.5 Dynamiker Biotechnology (Tianjin) Key News
7.17 ADVAITE
7.17.1 ADVAITE Corporate Summary
7.17.2 ADVAITE Business Overview
7.17.3 ADVAITE COVID-19 Diagnostic Testing Major Product Offerings
7.17.4 ADVAITE COVID-19 Diagnostic Testing Revenue in Global Market (2017-2022)
7.17.5 ADVAITE Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
Research Methodology:
COVID 19 Diagnostic Testing Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|